+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968715
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical excipient market is pivotal to advancing drug delivery and formulation capabilities, directly supporting evolving therapeutic and compliance needs across the pharmaceutical sector.

Market Snapshot: Pharmaceutical Excipient Market Size and Dynamics

The pharmaceutical excipient market grew from USD 9.22 billion in 2024 to USD 9.89 billion in 2025. Forecasts indicate steady expansion at a compound annual growth rate (CAGR) of 7.73%, reaching USD 14.42 billion by 2030. Growth is driven by advancements in delivery systems, increased emphasis on personalization, and heightened regulatory compliance across global markets.

Scope & Segmentation of the Pharmaceutical Excipient Market

This report delivers a deep dive into the core drivers and evolving dynamics shaping the excipient landscape. The analysis offers comprehensive segmentation across type, formulation, function, end-user, and distribution channel, as well as detailed regional insights and coverage of leading market players and innovations.

  • Excipient Types: Inorganic (calcium salts, halites, metal oxides), Organic (carbohydrates including cellulose, starch, sugars; oleochemicals like fatty alcohols, glycerin, mineral stearates; petrochemicals such as acrylic polymers, glycols, mineral hydrocarbons, povidones; proteins).
  • Formulation Routes: Oral (hard/soft gelatin capsules, tablets, liquid formulations), Parenteral, Topical.
  • Functional Roles: Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, Suspending & Viscosity Agents.
  • End-User Groups: Biopharmaceutical Companies, Contract Manufacturing Organizations, Pharmaceutical Companies, Research Laboratories.
  • Distribution Channels: Offline and Online networks.
  • Regions Covered: Americas (notably the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, among others), Asia-Pacific (China, India, Japan, Australia, South Korea, and further major markets).
  • Analyzed Companies: Leading global and regional suppliers such as ABITEC Corporation, BASF SE, Colorcon Inc., Ashland Inc., Croda International Plc, Roquette Frères S.A., and others, with focus on innovations, integrations, and digital solutions in excipient production and supply.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Pharmaceutical excipients now function as critical enablers, not inert fillers, influencing drug stability, targeted delivery, and patient experience in diverse therapeutic areas.
  • Regulatory agencies and harmonized pharmacopeial standards are increasing the demand for high-purity, traceable excipients and more transparent supply chains.
  • The surge in biologics, gene therapies, and personalized medicine is prompting suppliers to invest in advanced analytical techniques and develop novel multifunctional excipient systems.
  • Regional manufacturing strengths, particularly in Asia-Pacific, are shaping global supply resilience, while the Americas and EMEA emphasize quality, regulatory compliance, and innovation partnerships.
  • Digitalization, including blockchain-enabled traceability and IoT-based manufacturing, is reshaping quality control and delivery timelines for pharmaceutical excipients.
  • Closer supplier-manufacturer collaboration, sustainable sourcing, and contract manufacturing partnerships are key to supporting supply continuity and excipient customization in demanding market environments.

Tariff Impact: Navigating United States Revisions

Recent United States tariff revisions have altered cost structures for both raw and finished excipient materials, prompting companies to rethink procurement and manufacturing strategies. Firms are pursuing regional supply agreements and expanding domestic production to reduce cross-border risk and enhance access to critical excipient inputs. These adaptations have intensified the push for flexible sourcing and collaborative procurement models across the value chain.

Methodology & Data Sources

Data and insights are drawn from a rigorous multi-tiered research process. This includes in-depth interviews with industry experts, reviews of peer-reviewed journals and regulatory filings, and detailed analysis of supplier and production data. Quantitative mapping and expert validation ensure a reliable and actionable perspective on market drivers, segmentation, and evolving strategies.

Why This Report Matters to Senior Leadership

  • Enables evidence-based investment, R&D, and procurement strategies rooted in regional and segment trends.
  • Supports resilience planning by clarifying the impact of regulatory harmonization, tariff shifts, and digital transformation on the excipient sector.
  • Offers actionable benchmarking of innovation, partnership models, and sustainability initiatives among leading and emerging suppliers.

Conclusion

The pharmaceutical excipient market is evolving toward greater functionality, compliance, and digital integration. Strategic adaptability and robust collaboration will help organizations secure competitive advantage and operational continuity as formulation requirements and technologies advance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in silica-based glidants optimizing powder flow for high-speed tablet production under GMP conditions
5.2. Shift towards plant-based and clean-label excipients as patient demand for natural formulations increases
5.3. Adoption of co-processed excipients driving direct compression formulation efficiencies in tablet manufacturing
5.4. Integration of real-time analytical technologies in excipient manufacturing for continuous process verification
5.5. Rising regulatory focus on quality by design to standardize excipient production across global markets
5.6. Emergence of biodegradable polymer excipients to meet sustainability targets and reduce environmental impact
5.7. Supply chain diversification strategies to mitigate raw material shortages in pharmaceutical excipient markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Excipient Market, by Type
8.1. Introduction
8.2. Inorganic
8.2.1. Calcium Carbonate
8.2.2. Calcium Phosphate
8.2.3. Calcium Sulfate
8.2.4. Halites
8.2.5. Metal Oxides
8.3. Organic
8.3.1. Carbohydrates
8.3.1.1. Cellulose
8.3.1.2. Starch
8.3.1.3. Sugars
8.3.2. Oleochemicals
8.3.2.1. Fatty Alcohols
8.3.2.2. Glycerin
8.3.2.3. Mineral Stearates
8.3.3. Petrochemicals
8.3.3.1. Acrylic Polymers
8.3.3.2. Glycols
8.3.3.3. Mineral Hydrocarbons
8.3.3.4. Povidones
8.3.4. Proteins
9. Pharmaceutical Excipient Market, by Formulation
9.1. Introduction
9.2. Oral Formulations
9.2.1. Hard Gelatin Capsules
9.2.2. Liquid Formulations
9.2.3. Soft Gelatin Capsules
9.2.4. Tablets
9.3. Parenteral Formulations
9.4. Topical Formulations
10. Pharmaceutical Excipient Market, by Function
10.1. Introduction
10.2. Binders
10.3. Coating Agents
10.4. Colorants
10.5. Disintegrants
10.6. Emulsifying Agents
10.7. Fillers & Diluents
10.8. Flavoring Agents & Sweeteners
10.9. Lubricants & Glidants
10.10. Preservatives
10.11. Suspending & Viscosity Agents
11. Pharmaceutical Excipient Market, by End-User
11.1. Introduction
11.2. Biopharmaceutical Companies
11.3. Contract Manufacturing Organizations
11.4. Pharmaceutical Companies
11.5. Research Laboratories
12. Pharmaceutical Excipient Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Americas Pharmaceutical Excipient Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pharmaceutical Excipient Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pharmaceutical Excipient Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ABITEC Corporation
16.3.2. Actylis
16.3.3. Archer Daniels Midland Company
16.3.4. ARMOR PROTEINES S.A.S. by Savencia Group
16.3.5. Asahi Kasei Corporation
16.3.6. Ashland Inc.
16.3.7. BASF SE
16.3.8. BIOGRUND GmbH
16.3.9. Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
16.3.10. Clariant AG
16.3.11. Colorcon Inc.
16.3.12. Corel Pharma Chem Private Limited
16.3.13. Croda International Plc
16.3.14. Darling Ingredients, Inc.
16.3.15. DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
16.3.16. DuPont de Nemours, Inc.
16.3.17. Evonik Industries AG
16.3.18. Fuji Chemical Industries Co., Ltd.
16.3.19. GATTEFOSSE SAS
16.3.20. Innophos Holdings, Inc. by Iris Parent LLC
16.3.21. International Flavors & Fragrances Inc.
16.3.22. JRS PHARMA GmbH + Co. KG
16.3.23. Kerry Group P.L.C.
16.3.24. Lipoid GmbH
16.3.25. Lubrizol Corporation
16.3.26. L’AIR LIQUIDE S.A.
16.3.27. Mallinckrodt plc
16.3.28. MEGGLE GmbH & Co. KG
16.3.29. Merck KGaA
16.3.30. Nagase & Co., Ltd.
16.3.31. Nipon Soda Co., Ltd.
16.3.32. NOF Corporation
16.3.33. Omya International AG
16.3.34. Peter Greven GmbH & Co. KG
16.3.35. Roquette Frères S.A.
16.3.36. Shin-Etsu Chemical Co., Ltd.
16.3.37. Solvay S.A.
16.3.38. SPI Pharma, Inc.
16.3.39. Sumitomo Seika Chemicals Company, Limited
16.3.40. Thermo Fisher Scientific Inc.
16.3.41. Vanderbilt Minerals LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PHARMACEUTICAL EXCIPIENT MARKET: RESEARCHAI
FIGURE 26. PHARMACEUTICAL EXCIPIENT MARKET: RESEARCHSTATISTICS
FIGURE 27. PHARMACEUTICAL EXCIPIENT MARKET: RESEARCHCONTACTS
FIGURE 28. PHARMACEUTICAL EXCIPIENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 167. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 170. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 171. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 172. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 173. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 174. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 175. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 176. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 177. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 178. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 179. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 182. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 183. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 184. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 185. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 186. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 187. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 192. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 193. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 194. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 195. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 208. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 209. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 303. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2024 (USD MILLION)
TABLE 304. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2025-2030 (USD MILLION)
TABLE 305. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2024 (USD MILLION)
TABLE 306. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2025-2030 (USD MILLION)
TABLE 307. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2024 (USD MILLION)
TABLE 308. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2025-2030 (USD MILLION)
TABLE 309. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2024 (USD MILLION)
TABLE 312. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2025-2030 (USD MILLION)
TABLE 313. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 314. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 315. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 316. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 317. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2024 (USD MILLION)
TABLE 318. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2025-2030 (USD MILLION)
TABLE 319. GERMANY PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. GERMAN

Samples

Loading
LOADING...

Companies Mentioned

  • ABITEC Corporation
  • Actylis
  • Archer Daniels Midland Company
  • ARMOR PROTEINES S.A.S. by Savencia Group
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc. by Iris Parent LLC
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Lipoid GmbH
  • Lubrizol Corporation
  • L’AIR LIQUIDE S.A.
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay S.A.
  • SPI Pharma, Inc.
  • Sumitomo Seika Chemicals Company, Limited
  • Thermo Fisher Scientific Inc.
  • Vanderbilt Minerals LLC

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.42 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned41

Related Topics

Related Reports

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030 - Product Image

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030

  • Report
  • 633 Pages
  • Global
From
Organic Pharmaceutical Excipients Market by Product Type (Cellulose Derivatives, Gelatin, Inorganic Salts), Application (Injectable, Ophthalmic, Oral Solid Dosage), Form, Source - Global Forecast 2025-2030 - Product Image

Organic Pharmaceutical Excipients Market by Product Type (Cellulose Derivatives, Gelatin, Inorganic Salts), Application (Injectable, Ophthalmic, Oral Solid Dosage), Form, Source - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Nutraceutical Excipients Market by Type (Binders, Coatings, Disintegrants), Function (Anti-Caking Agents, Antioxidants, Emulsifiers), Form, Source, Application - Global Forecast 2025-2030 - Product Image

Nutraceutical Excipients Market by Type (Binders, Coatings, Disintegrants), Function (Anti-Caking Agents, Antioxidants, Emulsifiers), Form, Source, Application - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Organic Pharmaceutical Excipients Market Report 2025 - Product Image

Organic Pharmaceutical Excipients Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Excipients in Pharmaceuticals: Global Markets to 2029 - Product Image

Excipients in Pharmaceuticals: Global Markets to 2029

  • Report
  • 105 Pages
  • Global
From

About the Market

The Drug Excipient market is an important part of the Pharmaceutical industry. Drug Excipients are inactive ingredients used in the production of drugs and medications. They are used to bind, fill, dissolve, stabilize, and protect the active ingredients in a drug. Excipients are also used to improve the taste, texture, and appearance of a drug. Excipients are essential components of any drug formulation, as they can affect the safety, efficacy, and stability of the drug. The Drug Excipient market is highly competitive, with many companies offering a wide range of products. Companies in the market include BASF, Roquette, Ashland, Colorcon, Evonik, and Dow. These companies provide a variety of excipients, including fillers, binders, lubricants, disintegrants, glidants, and stabilizers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.